Cathleen Mullarkey Desapio, MD
Endocrinology, Diabetes & Metabolism · Princeton, NJNPI 1225073505
Payments from drug & device makers
Across 730 payments — averaging $250.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$68K
- Mannkind Corporation$38K
- Amarin Pharma, Inc.$16K
- Johnson & Johnson$16K
- AbbVie$15K
- Boehringer Ingelheim$14K
- plus $17K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 196 | $68,167 |
| Mannkind Corporation | 87 | $37,521 |
| Amarin Pharma, Inc. | 63 | $16,152 |
| Johnson & Johnson | 60 | $15,910 |
| AbbVie | 45 | $14,506 |
| Boehringer Ingelheim | 35 | $13,733 |
| Lilly USA, LLC | 29 | $6,832 |
| Medtronic(2 entities) | 27 | $2,599 |
| Corcept Therapeutics | 13 | $2,325 |
| Abbott | 15 | $962 |
| Novo Nordisk | 25 | $939 |
| Amneal Pharmaceuticals LLC | 31 | $539 |
| Sanofi-aventis U.S. LLC | 25 | $351 |
| Amgen(2 entities) | 15 | $240 |
| Dexcom, Inc. | 2 | $187 |
| BETA Bionics, Inc. | 2 | $167 |
| Insulet Corporation | 2 | $166 |
| Bayer | 2 | $144 |
| Kowa Pharmaceuticals America, Inc. | 10 | $138 |
| Shire North American Group Inc | 6 | $138 |
| Endo Pharmaceuticals Inc. | 9 | $115 |
| Tandem Diabetes Care, Inc. | 2 | $104 |
| Radius Health, Inc. | 4 | $98 |
| Janssen Scientific Affairs, LLC | 3 | $87 |
| Merck | 6 | $82 |
| Esperion Therapeutics, Inc. | 3 | $77 |
| Intuity Medical Inc | 1 | $69 |
| IBSA Pharma Inc. | 5 | $64 |
| Lifescan, Inc. | 2 | $31 |
| Companion Medical, Inc. | 2 | $28 |
| Antares Pharma, Inc. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$182,512 in reported general payments places this provider in the 95th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.
See all endocrinology, diabetes & metabolism providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Princeton
- Kunal ShahPrinceton$215K
- Alan MosesPrinceton$17K
- Angela InzerilloPrinceton$12K
- Barry GertzRahway$903K
- Nawras MakhsidaRandolph$882K
- Marc SandbergFlemington$567K
- Joanne WaldstreicherNew Brunswick$441K
- Gregory BaroneCherry Hill$433K
- Taher ModarressiPennington$414K
- Navtika DesaiHillsborough$408K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.